Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $340,500.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $11.35, for a total value of $340,500.00. Following the completion of the transaction, the insider now directly owns 1,696,097 shares of the company’s stock, valued at approximately $19,250,700.95. This represents a 1.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.77, for a total value of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The shares were sold at an average price of $9.02, for a total value of $63,807.48.

Alignment Healthcare Trading Down 10.5 %

NASDAQ:ALHC opened at $11.48 on Monday. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $14.25. The company has a market cap of $2.20 billion, a P/E ratio of -14.92 and a beta of 1.45. The stock’s fifty day moving average price is $11.59 and its two-hundred day moving average price is $9.41.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. During the same quarter last year, the business posted ($0.19) earnings per share. The firm’s revenue was up 51.6% compared to the same quarter last year. As a group, analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. nVerses Capital LLC purchased a new stake in shares of Alignment Healthcare in the third quarter worth $95,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Alignment Healthcare in the third quarter worth $131,000. Virtu Financial LLC purchased a new stake in shares of Alignment Healthcare in the first quarter worth $57,000. Creative Planning raised its position in shares of Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after buying an additional 2,072 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after purchasing an additional 2,077 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

ALHC has been the subject of several recent analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. KeyCorp began coverage on Alignment Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. UBS Group increased their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Robert W. Baird increased their price objective on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. Finally, TD Cowen increased their target price on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research report on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $10.33.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.